approval
saveLAMICTAL XR (LAMOTRIGINE) — FDA approval
community read0 votes
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalLAMOTRIGINE — FDA approvalApr 17, 2026 · 167d ago
- approvalLAMOTRIGINE — FDA approvalApr 17, 2026 · 167d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 174d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 174d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 174d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 174d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 174d ago
- approvalLAMOTRIGINE — FDA approvalApr 9, 2026 · 175d ago
same company · ±60 days · 6
- approvalLAMOTRIGINE: LAMICTAL XR (LAMOTRIGINE) — FDA approvalApr 14, 2010
- approvalVALACYCLOVIR HYDROCHLORIDE: VALTREX (VALACYCLOVIR HYDROCHLORIDE) — FDA approvalApr 19, 2010
- approvalBUPROPION HYDROCHLORIDE: WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approvalMay 25, 2010
- approvalBUPROPION HYDROCHLORIDE: WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approvalMay 25, 2010
- approvalBUPROPION HYDROCHLORIDE: WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approvalFeb 26, 2010
- approvalBUPROPION HYDROCHLORIDE: WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approvalFeb 26, 2010
comments(0)
5-min edit window · permanent after that